Your browser doesn't support javascript.
loading
Recombinant Adeno-Associated Virus Quality Control for Non-Clinical and Clinical Vectors: How an Unregulated Commercial Sector Can Compromise Development of New Gene Therapies.
Kotin, Robert M; Wright, J Fraser.
Affiliation
  • Kotin RM; Horae Gene Therapy Center and Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts.
  • Wright JF; Department of Pediatrics, Center for Definitive and Curative Medicine, Stanford University School of Medicine, Stanford, California.
Hum Gene Ther ; 30(12): 1447-1448, 2019 12.
Article in En | MEDLINE | ID: mdl-31860397
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Therapy / Dependovirus / Genetic Vectors Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Hum Gene Ther Year: 2019 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Therapy / Dependovirus / Genetic Vectors Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Hum Gene Ther Year: 2019 Document type: Article